Ask AI
ProCE Banner Series

Expanding Options in CLL/SLL–What Hematology/Oncology Nurses Need to Know

Don’t miss this expert guidance on the current and expanding treatment options in chronic lymphocytic leukemia, curated for hematology and oncology nurses.

  ANCC
Who Should Attend

This activity has been designed to meet the educational needs of nurse practitioners, oncology nurses, and other healthcare professionals involved in the management of CLL/SLL.

All Events

Expanding Options in CLL/SLL–What Hematology/Oncology Nurses Need to Know

Upcoming Events

March

31

2026

6:15 PM - 7:15 PM Eastern Time (ET)

Virtual

Simulcast | Host Group NC, New Bern, North Carolina

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learner knowledge and competence in optimizing the care of patients with CLL/SLL who are receiving treatment with targeted agents.

Target Audience
This activity has been designed to meet the educational needs of nurse practitioners, oncology nurses, and other healthcare professionals involved in the management of CLL/SLL.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain targeted agents to patients with CLL/SLL according to their rationale, mechanisms of action, efficacy, and adverse event profiles

  • Support patients’ goals and preferences when receiving treatment for newly diagnosed or relapsed/refractory CLL/SLL, considering prognostic variables, comorbidities, duration, and toxicity profiles

  • Evaluate current and emerging efficacy and safety evidence for the use of targeted agents, including CAR T-cells, in first-line, second-line, and later-line treatment of CLL/SLL

  • Identify and manage adverse events associated with targeted agents for CLL/SLL to improve duration on treatment and clinical outcomes

  • Use enhanced communication strategies to support patient engagement in care, including strategies to recognize and address adverse events, drug interactions, and treatment adherence 

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from BeOne Medicines USA Inc. and Lilly.

BeOne Medicines USA Inc.

Lilly

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191